Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Duval

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|May 18, 2011
Low systemic ganciclovir exposure and preemptive treatment failure of cytomegalovirus reactivation in a transplanted childJulie Autmizguine, Yves Théôret, Elise Launay, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 13, 2017
Activation of innate immunity in primary human cells using a plant virus derived nanoparticle TLR7/8 agonistDamien Carignan, Sabine Herblot, Marie-Ève Laliberté-Gagné, et al.
Pediatric Research|February 19, 2005
Characterization of cord blood natural killer cells: implications for transplantation and neonatal infectionsJean-Hugues Dalle, José Menezes, Eric Wagner, et al.
Cancer Immunology, Immunotherapy : CII|April 29, 2020
Patients' NK cell stimulation with activated plasmacytoid dendritic cells increases dinutuximab-induced neuroblastoma killingAssila Belounis, Marina Ayoub, Paulo Cordeiro, et al.
Cytotherapy|February 18, 2014
Implication of different effector mechanisms by cord blood-derived and peripheral blood-derived cytokine-induced killer cells to kill precursor B acute lymphoblastic leukemia cell linesLudovic Durrieu, William Lemieux, Mame Massar Dieng, et al.
Plos One|April 3, 2018
Pharmacokinetics-adapted Busulfan-based myeloablative conditioning before unrelated umbilical cord blood transplantation for myeloid malignancies in childrenJoy Benadiba, Marc Ansari, Maja Krajinovic, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 11, 2012
Excess of veno-occlusive disease in a randomized clinical trial on a higher trigger for red blood cell transfusion after bone marrow transplantation: a canadian blood and marrow transplant group trialNancy Robitaille, Jacques Lacroix, Lubomir Alexandrov, et al.
Plos One|September 16, 2016
Improvement of the Outcome of Relapsed or Refractory Acute Lymphoblastic Leukemia in Children Using a Risk-Based Treatment StrategyFrancesco Ceppi, Michel Duval, Jean-Marie Leclerc, et al.
Pediatric Transplantation|March 15, 2011
Secondary pulmonary alveolar proteinosis after unrelated cord blood hematopoietic cell transplantationMarc Ansari, Anne-Laure Rougemont, Françoise Le Deist, et al.
Cellular Immunology|May 15, 2012
Post-transcriptional down-regulation of Toll-like receptor signaling pathway in umbilical cord blood plasmacytoid dendritic cellsEmily Charrier, Paulo Cordeiro, Martine Cordeau, et al.
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|May 18, 2011
Low systemic ganciclovir exposure and preemptive treatment failure of cytomegalovirus reactivation in a transplanted childJulie Autmizguine, Yves Théôret, Elise Launay, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 13, 2017
Activation of innate immunity in primary human cells using a plant virus derived nanoparticle TLR7/8 agonistDamien Carignan, Sabine Herblot, Marie-Ève Laliberté-Gagné, et al.
Pediatric Research|February 19, 2005
Characterization of cord blood natural killer cells: implications for transplantation and neonatal infectionsJean-Hugues Dalle, José Menezes, Eric Wagner, et al.
Cancer Immunology, Immunotherapy : CII|April 29, 2020
Patients' NK cell stimulation with activated plasmacytoid dendritic cells increases dinutuximab-induced neuroblastoma killingAssila Belounis, Marina Ayoub, Paulo Cordeiro, et al.
Cytotherapy|February 18, 2014
Implication of different effector mechanisms by cord blood-derived and peripheral blood-derived cytokine-induced killer cells to kill precursor B acute lymphoblastic leukemia cell linesLudovic Durrieu, William Lemieux, Mame Massar Dieng, et al.
Plos One|April 3, 2018
Pharmacokinetics-adapted Busulfan-based myeloablative conditioning before unrelated umbilical cord blood transplantation for myeloid malignancies in childrenJoy Benadiba, Marc Ansari, Maja Krajinovic, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 11, 2012
Excess of veno-occlusive disease in a randomized clinical trial on a higher trigger for red blood cell transfusion after bone marrow transplantation: a canadian blood and marrow transplant group trialNancy Robitaille, Jacques Lacroix, Lubomir Alexandrov, et al.
Plos One|September 16, 2016
Improvement of the Outcome of Relapsed or Refractory Acute Lymphoblastic Leukemia in Children Using a Risk-Based Treatment StrategyFrancesco Ceppi, Michel Duval, Jean-Marie Leclerc, et al.
Pediatric Transplantation|March 15, 2011
Secondary pulmonary alveolar proteinosis after unrelated cord blood hematopoietic cell transplantationMarc Ansari, Anne-Laure Rougemont, Françoise Le Deist, et al.
Cellular Immunology|May 15, 2012
Post-transcriptional down-regulation of Toll-like receptor signaling pathway in umbilical cord blood plasmacytoid dendritic cellsEmily Charrier, Paulo Cordeiro, Martine Cordeau, et al.
Pageof 11